Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Tongluohuoxue Formula
- Development stage
- Preclinical
- Lead developer
- First Affiliated Hospital of Guangzhou University of Chinese Medicine
- Administration
- Topical
01
Overview
Tongluohuoxue Formula is a Traditional Chinese Medicine (TCM) herbal formula. Its name, which translates to "unblocking collaterals and activating blood circulation," reflects its traditional therapeutic principles. The formula is currently under investigation in a multicenter, double-blind, placebo-controlled clinical trial for the prevention and management of paclitaxel-induced peripheral neuropathy. In this trial, it is administered topically.
- Other names
- Tongluo Huoxue FormulaTongluo Huoxue DecoctionTongluo Huoxue Recipe
02
Targets
AKT1 (Proto-oncogene serine/threonine-protein kinase Akt1)IKBKE (IκB kinase epsilon)NF-κBIL-6 (Interleukin 6)TNFA (Tumor necrosis factor alpha (soluble))
Beyond the preview
Go deeper on Tongluohuoxue Formula.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Tongluohuoxue Formula.